scispace - formally typeset
C

Chaoyong Yang

Researcher at Xiamen University

Publications -  114
Citations -  3725

Chaoyong Yang is an academic researcher from Xiamen University. The author has contributed to research in topics: Aptamer & Systematic evolution of ligands by exponential enrichment. The author has an hindex of 24, co-authored 114 publications receiving 1781 citations. Previous affiliations of Chaoyong Yang include Shanghai Jiao Tong University.

Papers
More filters
Journal ArticleDOI

Discovery of Aptamers Targeting the Receptor-Binding Domain of the SARS-CoV-2 Spike Glycoprotein.

TL;DR: This study identified high-binding-affinity aptamers targeting SARS-CoV-2 RBD, using an ACE2 competition-based aptamer selection strategy and a machine learning screening algorithm, and suggests that two aptamer may have partially identical binding sites at ACE2 on Sars- coV- 2 RBD.
Journal ArticleDOI

Aptamer-Based Detection of Circulating Targets for Precision Medicine.

TL;DR: A broad overview of aptamer-based liquid biopsy techniques for precision medicine can be found in this article, where the authors present a summary of state-of-the-art strategies for multivalent aptamer assembly and aptamer interface modification.
Journal ArticleDOI

Enrichment and single-cell analysis of circulating tumor cells

TL;DR: This review aims to provide in-depth insights into CTC analysis, including various techniques for isolation of C TCs and single-cell analysis of CTCs, as well as current developmental trends and promising research directions.
Journal ArticleDOI

Design and Synthesis of Target-Responsive Aptamer-Cross-linked Hydrogel for Visual Quantitative Detection of Ochratoxin A

TL;DR: The integration of a target-responsive hydrogel with portable enrichment by IAC, as well as signal amplification and quantitative readout by a simple microfluidic device, offers a new method for portable detection of food safety hazard toxin OTA.
Journal ArticleDOI

Aptamer Blocking Strategy Inhibits SARS-CoV-2 Virus Infection.

TL;DR: In this paper, an aptamer blocking strategy was proposed by engineering aptamers' binding to the region on SRBD that directly mediates ACE2 receptor engagement, leading to block SARS-CoV-2 infection.